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A B S T R A C T
Trypanosoma brucei causes human African trypanosomiasis and Nagana disease in cattle, imposing substantial medical and economic burden in sub-Saharan Africa.
The current treatments have limitations, including the requirement for elaborated protocols, development of drug resistance, and they are prone to adverse side
eﬀects. In vitro screening of a library of 14 dinuclear-thiolato bridged arene ruthenium complexes, originally developed for treatment of cancer cells, resulted in the
identiﬁcation of 7 compounds with IC50 values ranging from 3 to 26 nM. Complex [(η6-p-MeC6H4Pri)2Ru2(μ2-SC6H4-o-Pri)3]Cl (2) (IC50= 4 nM) and complex [(η6-p-
MeC6H4Pri)2Ru2(μ2-SCH2C6H4-p-But)2(μ2-SC6H4-p-OH)]BF4 (9) (IC50= 26 nM) were chosen for further assessments. Application of complex 2 and 9 at 20 nM and
200 nM, respectively, for 4.5 h induced alterations in the trypanosome mitochondrion as evidenced by immunoﬂuorescence employing an antibody against mi-
tochondrial Hsp70 and Mitotracker labeling. Transmission electron microscopy of parasites taken at 2 and 4h of treatment demonstrated massive alterations in the
mitochondrial ultrastructure, while other organelles and structural elements of the parasites remained unaﬀected. Complex 2 treated trypanosomes exhibited a
distorted mitochondrial membrane, and the mitochondrial matrix was transformed into an amorphous mass with diﬀerent degrees of electron densities. Complex 9
did not notably impair the integrity of the membrane, but the interior of the mitochondrion appeared either completely translucent, or was ﬁlled with ﬁlamentous
structures of unknown nature. Dose- and time-dependent eﬀects of these two compounds on the mitochondrial membrane potential were detected by tetra-
methylrhodamine ethyl ester assay. Thus, the mitochondrion and associated metabolic processes are an important target of dinuclear thiolato-bridged arene ru-
thenium complexes in T. brucei.
1. Introduction
Human African trypanosomiasis (HAT), also referred to as African
sleeping sickness, is induced by infection with the ﬂagellated protozoan
parasites Trypanosoma brucei gambiense and T. b. rhodesiense. While T. b.
gambiense is responsible for 98% of all HAT cases, causing chronic in-
fection, and is found in Western and Central Africa, T. b. rhodesiense
causes a rapidly progressive form of the disease, and is found in Eastern
and Southern Africa (Franco et al., 2014). Another T. brucei subspecies,
T. b. brucei, is one of the causative agents of a wasting disease in cattle,
called Nagana, aﬀecting agricultural production and animal husbandry
and causing high economic and social impact in African rural areas
(Giordani et al., 2016). The drugs in clinical use for the treatment of
HAT include pentamidine and suramin for the early and peripheral
stage of the disease, and melarsoprol and eﬂornithine alone or in
combination with nifurtimox for the cerebral phase (Büscher et al.,
2017). Novel drugs being evaluated in phase II/III clinical trials include
oxaborole (SCYX-7158), a benzoxaborole, and the 2-5-nitroimidazole
fexinidazole that has recently been approved for human use (www.
dndi.org). Veterinary trypanocides to treat Nagana include diminazene
aceturate and isometamidium chloride as the two most commonly used
drugs (Holmes, 2013).
One of the characteristics of the trypanosomatids is that they harbor
only one mitochondrion per cell, compared to mammalian cells, which
typically possess hundreds of individual mitochondria. In addition,
unlike most other eukaryotes, the trypanosome mitochondrion contains
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a single-unit mitochondrial genome, termed kinetoplast (Schneider and
Oschsenreiter, 2018). The T. brucei life cycle alternates between the
tsetse ﬂy vector and a mammalian host. Mammalian bloodstream form
trypanosomes rely almost entirely on glycolysis for energy production
and lack oxidative phosphorylation (Priest and Hajduk, 1994). As re-
vealed by ﬂuorescence and transmission electron microscopy (TEM),
the bloodstream form mitochondrion adopts a tube-like structure that
stretches throughout the entire cell body and is largely devoid of
cristae. The kinetoplast is located in a dilated area of the mitochondrion
and is physically associated with the ﬂagellar base and the ﬂagellar
pocket (Schneider and Oschsenreiter, 2018). Although the respiratory
chain is not functional in T. brucei bloodstream forms, the mitochon-
drion is essential for parasite survival. Thus, compounds targeting mi-
tochondrial function and structural integrity represent attractive drug
candidates.
Metallodrugs are widely employed both for diagnosis and therapy of
a wide range of diseases, and have been generated using platinum,
copper, gold or ruthenium for the application in cancer but also for
combating infectious diseases caused by bacteria Southam et al. (2017),
helminths (Hess et al., 2015; Küster et al., 2012), and protozoan
parasites. We have previously reported that several mononuclear and
dinuclear thiolato-bridged ruthenium complexes exhibit promising in
vitro activities against the intracellular apicomplexan parasites Tox-
oplasma gondii and Neospora caninum (Basto et al., 2017, 2019). They
were shown to eﬃciently inhibit host cell invasion, had an IC50 in the
low nanomolar range, low host cell toxicity, and exposure of parasites
to these compounds led to distinct alterations in the ultrastructure of
the parasite mitochondrion.
Fig. 1. Structures of the investigated dinuclear thiolato-bridged arene ruthenium complexes. (1–7) are cationic symmetrical trithiolato complexes bearing one type of
thiol ligand, (8–9) are cationic mixed trithiolato complexes bearing two diﬀerent thiol ligands, and (10–14) are neutral dithiolato complexes bearing one type of thiol
ligand).
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Organometallic complexes have been explored previously for the
treatment of African trypanosomiasis (Ravera et al., 2018), but also for
Chagas disease caused by Trypanosoma cruzi in South America, for
which the current drugs do not satisfy the needs for safe and easy-to-use
application procedures, and drug resistance is becoming a major pro-
blem (Southam et al., 2017). Previously designed compounds include
Ru(II)–NO donor drugs that have potent activity against T. cruzi in vitro
and in animal models, with one trans-[Ru(NO) (NH3)4imN](BF4)3
compound exhibiting 10-fold higher anti-trypanosomal activity than
others (Silva et al., 2009). A series of novel cis-[Ru(NO)(bpy)2L]Xn]
compounds were speciﬁcally designed to target T. cruzi glyceraldehyde
3-phosphate dehydrogenase, and when assessed against T. cruzi trypo-
mastigotes, epimastigotes and amastigotes in Vero cells, respective
compounds were 1000-fold more active against T. cruzi than benzni-
dazole, the standard drug used for the treatment of Chagas disease
(Silva et al., 2010). Anti-T. cruzi and anti-T. brucei activities were also
demonstrated for Ru(II)-cyclopentadienyl complexes. Three complexes
with the general structure [Ru(η5-C5H5)(PPh3)L] exhibited good se-
lectivity indexes for T. cruzi (> 49) and T. brucei (> 6), with IC50 values
in the micromolar range (Fernandez et al., 2015). These complexes
interact with DNA and cause the generation of free radicals. A novel Ru
(II)-cyclopentadienyl (Cp) clotrimazole (CTZ) complex [RuCp
(PPh3)2(CTZ)](CF3SO3) was shown to be active against T. cruzi and T.
brucei, and against several human tumor cell lines (Arce et al., 2015).
This complex did not interact with DNA, but aﬀected the conversion of
sequalene to sequalene oxide in the sterol biosynthetic pathway in T.
cruzi (Arce et al., 2015).
In this study, we investigated the in vitro activities of a small panel
of 14 dinuclear thiolato-bridged arene ruthenium complexes against T.
brucei bloodstream forms in culture.
2. Materials and methods
2.1. Chemicals and synthesis of ruthenium complexes
All reagents for chemical synthesis were commercially available.
The synthesis of complexes 1–14 was reported previously (Basto et al.,
2017, 2019). All complexes were isolated as chloride or tetra-
ﬂuoroborate salts, were stable orange to red solids, and were dried in
vacuum.
2.2. Culture of T. b. brucei bloodstream forms
T. b. brucei 427 bloodstream forms co-expressing T7 RNA poly-
merase and tetracycline repressor (Wirtz et al., 1999) were cultured in
HMI-9 medium (Hesse et al., 1995) containing 10% heat-inactivated
fetal bovine serum. Cultures were maintained under humidiﬁed con-
ditions in 5% CO2 at 37 °C.
2.3. In vitro drug screening and IC50 determination
Stock solutions of complexes (1 mM) were prepared in DMSO, he-
ated or sonicated if necessary, and stored at room temperature. Each
compound was tested at concentrations ranging from 250 nM to 0.1 nM
(ﬁnal concentrations in the assay). The concentration of DMSO in the
assay was<0.25% (v/v), i.e. a concentration at which parasite growth
is not aﬀected. The stability of the complexes in water/DMSO mixtures
has been demonstrated previously (Basto et al., 2017, 2019). Screenings
and IC50 calculations were done as follows: Assays were performed in
96-well ﬂat-bottom plates, with each well containing 1.5×103 para-
sites in 100 μl culture medium with or without a serial drug dilution.
Ten 2-fold drug dilutions were used. After 72 h of compound exposure,
10 μl AlamarBlue® (Resazurin; Sigma) was added to each well allowing
a colour change via metabolic oxidation-reduction by viable trypano-
somes during 2–3 h. Subsequently, plates were read with a Flexstation II
microplate ﬂuorimeter using an excitation wave length of 536 nm and
an emission wave length of 588 nm. IC50 values were determined using
the software GraphPad Prism 6. Inhibition of trypanosome growth by
pentamidine was measured in each plate as internal positive control.
2.4. (Immuno-) Fluorescence microscopy
Staining of mitochondrial HSP70 (mtHSP70): Trypanosomes
(5×106 cells/ml) cultured in 24-well ﬂat-bottom plates for 4.5 h in the
absence or presence of drugs (20 nM or 200 nM, ﬁnal concentrations)
were collected in Eppendorf tubes and washed once with phosphate-
buﬀered saline (PBS; 137mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4,
1.76mM KH2PO4, pH 7.4) and resuspended in PBS containing 1% (w/v)
paraformaldehyde. After incubation for 3min at room temperature,
ﬁxed parasites were washed with PBS before being allowed to adhere
onto poly-l-lysine-coated slides (Sigma). After treatment with methanol
for 5min at −20 °C, parasite preparations were air-dried for 5min at
Table 1
The eﬃcacies (IC50s) of dinuclear thiolate-bridged arene ruthenium complexes
on T. b. brucei bloodstream forms, and for comparison, in human foreskin ﬁ-
broblasts (HFF). aChloride salts of the corresponding thiols of the complexes
[1–7] and BF4 salts for [8 and 9] were used for experiments. b data from Basto
et al. (2017). c The log P values correspond to the values calculated for the thiol
RSH groups. n, number of independent determinations. ND, not determined.
Complexa T. b. brucei IC50
(nM)
n HFF
IC50 (μM)b
LogP (RSH)c (RSH)
1 4.2 ± 1.2 2 800 3.49 ± 0.36 4-C6H4-CF3
2 4.1 ± 1.3 5 > 1000 3.86 ± 0.28 2-C6H4–CH(CH3)2
4 29.3 ± 3.7 2 ND 3.44 ± 0.28 3,5-C6H3-(CH3)2
5 4.1 1 ND 3.10 ± 0.29 3-C6H4–Cl
6 3.2 ± 1.7 3 2.8 4.74 ± 0.47 3,5-C6H3-(CF3)2
7 9.0 ± 1.1 2 ND 2.98 ± 0.28 2-C6H4–CH3
8 8.6 1 ND 2.20 ± 0.28 R1: CH2-4-
C6H4–OCH3
R2: 4-C6H4–OH
9 25.6 ± 4.7 5 5.1 3.38 ± 0.29 R1: CH2-4-C6H4-
(CCH3)3
R2: 4-C6H4–OH
Fig. 2. Representative inhibition curves for complexes 2 and 9.
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room temperature, humidiﬁed with PBS for 5min and permeabilized
with PBS containing 0.2% (w/v) Triton X-100 for 5min. After blocking
unspeciﬁc binding with PBS containing 2% (w/v) bovine serum al-
bumin (blocking solution) for 30min, parasites were exposed for
45min to mouse α-mtHSP70 antibody (kindly provided by Paul
Englund, Baltimore) at a dilution of 1:500 in blocking solution. After
washing with PBS, goat α-mouse AlexaFluor 594 antibody (Invitrogen)
at dilution of 1:1000 in blocking solution was added for 45min. After
washing and airdrying, cells were mounted with Vectashield containing
DAPI. Fluorescence microscopy was performed with a Leica DMI6000 B
inverted microscope using a 63x oil objective. Pictures were acquired,
processed and 3D-deconvolved with Leica LAS AF Version 2.1.0 soft-
ware (Leica Microsystems CMS GmbH).
Mitotracker staining: Trypanosomes (5×106 cells/ml) cultured in
24-well ﬂat-bottom plates for 4 h in the absence or presence of drugs
were exposed to MitoTracker™ Red CMXRos (Thermo Fisher Scientiﬁc;
0.1 μM in PBS) for 30min. Parasites were then collected in Eppendorf
tubes and washed with PBS containing 1% (w/v) paraformaldehyde.
After incubation for 3min at room temperature, cells were washed with
PBS before being allowed to adhere onto poly-l-lysine-coated slides and
air-dry for 5min. Methanol treatment, air-drying, mounting on glass
and examination by ﬂuorescence microscopy was done as described
above.
2.5. Transmission electron microscopy
Parasites exposed to drugs and control cultures during 2 or 4 h were
washed in cold 100mM sodium cacodylate buﬀer (pH 7.2) and re-
suspended in the same buﬀer containing 2.5% (v/v) glutaraldehyde.
Cells were ﬁxed for 2 h at room temperature, followed by post-ﬁxation
in 2% OsO4 in cacodylate buﬀer (pH 7.3). After three washes in distilled
water, samples were pre-stained in Uranyless solution (Electron
Microscopy Sciences, Hatﬁeld, PA, USA) in distilled water for 20min at
room temperature and extensively washed in distilled water.
Dehydration was carried out by stepwise incubation in ethanol (30%-
50%-70%-90%–100%). Parasites were then embedded in EPON812
Fig. 3. Immunoﬂuorescence staining of mtHSP70 and Mitotracker staining of T. b. brucei bloodstream forms treated with complex 2. Anti-mtHSP70-labelled control
trypanosomes are shown in A and C, trypanosomes exposed to 20 nM complex 2 during 4.5 h are depicted in B and D. Note a punctate staining pattern as indicated by
arrows. Mitotracker staining of control parasites is shown in E and G, while complex 2-treated parasites are shown in F and H, with yellow asterisks indicating
diminished labeling intensity. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the Web version of this article.)
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resin as described previously (Basto et al., 2017, 2019). Sections
(80 nm) were cut on an ultramicrotome (Reichert & Jung, Vienna,
Austria), placed onto 300-mesh formvar-carbon-coated nickel grids
(Plano, Wetzlar, Germany), and sections were stained with Uranyless
and lead citrate. Specimens were viewed on a CM12 transmission
electron microscope operating at 60 kV.
2.6. Tetramethylrhodamine ethyl ester (TMRE) assay
Trypanosomes (5× 106 cells/ml) cultured in 24-well ﬂat-bottom
plates for 2 h in the absence or presence of drugs were exposed for
30min to TMRE (200 nM ﬁnal concentration). Control trypanosomes
were treated for 10min with 25 μM carbonyl cyanide 3-chlor-
ophenylhydrazone (CCCP; Sigma) to cause depolarization of the inner
mitochondrial membrane. Parasites were then washed with PBS, re-
suspended in PBS and transferred to black 96-well ﬂat-bottom plates,
with each well containing 100 μl of sample. All samples were analyzed
in triplicates. The plates were read with a TECAN Spark ﬂuorescence
plate reader, using an excitation wave length of 535 nm and an emis-
sion wave length of 595 nm. Quantiﬁcation was done using the software
GraphPad Prism 6. The values represent means ± standard deviations
of triplicate determinations from 2 (complex 2) and 3 (complex 9) in-
dependent biological replicates. Statistical analysis was done by
Kruskal-Wallis test, followed by Dunn's multiple comparison test.
P < 0.05 indicated signiﬁcant diﬀerences in TMRE signals in drug-
treated parasites compared to the non-treated control.
3. Results
3.1. In vitro screening of dinuclear thiolato-bridged arene ruthenium
complexes identiﬁes several highly active compounds with anti-trypanosomal
activity
A small library of 14 dinuclear thiolato-bridged arene ruthenium
complexes (Fig. 1) was screened to search for compounds with in vitro
activity against T. b. brucei bloodstream forms. This library en-
compasses 7 cationic trithiolato complexes [(η6-p-MeC6H4Pri)2Ru2(μ2-
SC6H4-R)3]Cl bearing one type of thiol ligand (1–7), 2 cationic mixed
trithiolato complexes [(η6-p-MeC6H4Pri)2Ru2(μ2-SCH2C6H4-R)2(μ2-
SC6H4-R)]BF4 bearing two diﬀerent thiol ligands (8–9), and 5 neutral
dithiolato complexes [(η6-p-MeC6H4Pri)2Ru2(μ2-SCH2C6H4-p-R)2Cl2]
bearing one type of thiol ligand (10–14). Each compound was tested for
Fig. 4. Immunoﬂuorescence staining of mtHSP70
and Mitotracker staining of T. b. brucei bloodstream
forms treated with complex 9. Anti-mtHSP70-la-
belled control trypanosomes are shown in A and C,
trypanosomes exposed to 200 nM complex 9 during
4.5 h are depicted in B and D. Note a more punctate
staining pattern as indicated by arrows. Mitotracker
staining of control parasites is shown in E and G,
while complex 9-treated parasites are shown in F and
H, with yellow asterisks indicating slightly dimin-
ished labeling intensity. (For interpretation of the
references to colour in this ﬁgure legend, the reader
is referred to the Web version of this article.)
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impairment of T. b. brucei bloodstream form viability between 250 nM
and 0.1 nM (ﬁnal concentrations in the assay). For 7 compounds, the
IC50 values were> 100 nM and, thus, the compounds were no longer
included in further analyses. In contrast, complexes 1, 2 and 4–9 ex-
hibited strong viability impairment. Their respective IC50 values are
depicted in Table 1, and presented in relation to their logP in Fig. 2A.
Six complexes had IC50 values between 3 and 10 nM (complexes 1, 2,
5–8), while the IC50 values of complexes 4 and 9 were around 30 nM.
Cytotoxicity of these complexes for human foreskin ﬁbroblasts (HFF)
monolayers was very low. Selective toxicity indexes (trypanosomes
versus HFF) for complexes 1 and 2 were>250′000. For compounds 6
and 9, the respective IC50 values in HFF were 2.8 and 5.1 μM, i.e. ap-
proximately 930 and 215 times higher than for trypanosomes, respec-
tively. Complexes 2 and 9, with their respective inhibition curves
shown in Fig. 2B, were studied in more detail.
3.2. Complexes 2 and 9 aﬀect the mitochondrion
Previous investigations in the intracellular apicomplexan parasites
T. gondii and N. caninum showed that ruthenium complexes primarily
aﬀected the ultrastructure of the parasite mitochondrion [10, 11]. To
study potential mitochondrial alterations induced by these drugs in T. b.
brucei, parasites were exposed to complex 2 (20 nM, ~5 x IC50) and
complex 9 (200 nM, ~8 x IC50) during 4.5 h, and trypanosomes were
stained by immunoﬂuorescence using antibodies directed against the
mitochondrial marker protein mtHSP70, or with Mitotracker, a ﬂuor-
escent dye that incorporates into mitochondria only when the mem-
brane potential is intact [19],
In control untreated trypanosomes, anti-mtHSP70 stained the entire
length of the mitochondrion (Fig. 3A, C and 4A, C). In contrast, treat-
ment parasites with 20 nM complex 2 resulted in a more punctated
mitochondrial staining (Fig. 3B, D), and a similar staining pattern, al-
though a bit less pronounced, was observed after a 4.5 h treatment with
200 nM complex 9 (Fig. 4B, D). Mitotracker staining of complex 2-
treated parasites resulted in diminished labeling, suggesting a drug-
induced decrease in mitochondrial membrane potential (Fig. 3E–H). A
similar eﬀect on Mitotracker staining was also seen after exposure of
parasites to complex 9, although the loss in staining intensity was less
evident (Fig. 4E–H). Further evidence for drug-dependent loss of mi-
tochondrial membrane potential was obtained using TMRE as indicator
(Fig. 5). TMRE signals were clearly diminished upon exposure of
parasites to complexes 2 or 9 in a time- and concentration-dependent
manner.
3.3. Detection of drug-induced mitochondrial damage by TEM
T. b. brucei bloodstream forms were exposed to 20 nM complex 2,
200 nM complex 9, or the corresponding vehicle during 2 and 4 h, and
were ﬁxed and processed for TEM. Sections of non-treated and vehicle-
treated trypanosomes revealed the typical ultrastructural features of T.
b. brucei, including a ﬂagellum and a cell body with a nucleus con-
taining an electron dense nucleolus, and the mitochondrion of which
diﬀerent parts were visible within the entire cytoplasm as more electron
dense vesiculated entities on a single section (Fig. 6A). Higher magni-
ﬁcation views exposed subpellicular microtubules that form the cytos-
keleton of African trypanosomes, the Golgi-apparatus, the ﬂagellar
pocket, representing the site where the ﬂagellum emerges from the cell
body and runs along the longitudinal axis of the parasite, and the ki-
netoplast composed of mitochondrial DNA, closely associated with
ﬂagellum and ﬂagellar pocket. While the mitochondrial matrix appears
electron dense, only few cristae-like structures are visible in blood-
stream form trypanosomes. After exposure of T. b. brucei bloodstream
forms to complex 2 for 2 h (Fig. 7A and B) or 4 h (7C, D), the following
structural alterations were observed: The mitochondrial membrane
appeared distorted and poorly visible in some areas, and the mi-
tochondrial matrix had lost its electron dense texture and appeared as
amorphous, undeﬁned area (Fig. 7A–D). In addition, mitochondrial
swelling was observed, with the organelle occupying a larger part of the
cytoplasm compared to non-treated cells. This was also the case for the
region surrounding the kinetoplast at both time points (Fig. 7E and F).
In contrast, other organelles of the parasite, such as the Golgi appa-
ratus, did not appear to be structurally aﬀected after exposure to
complex 2.
Complex 9, applied at 200 nM, also aﬀected the ultrastructure of the
mitochondrion, but the eﬀects were diﬀerent compared to complex 2-
treated parasites (Fig. 8A–D). The mitochondrial membrane was
structurally mostly intact, and the matrix in complex 9-treated trypa-
nosomes was not ﬁlled with an amorphous substance, but with ﬁla-
mentous material of unknown composition. As for complex 2, other
organelles including the cytoskeleton, ﬂagellar pocket and the Golgi-
apparatus remained largely unaﬀected by treatment with complex 9.
4. Discussion
We here report on promising in vitro activities of a panel of
Fig. 5. Dose- and time-dependent impairment of the mitochondrial membrane
potential as measured by TMRE uptake. Trypanosomes were exposed to 20 nM
complex 2 during 2 or 4 h, or to 100 or 200 nM complex 9 during 2 and 4 h,
respectively. The uncoupler CCCP was used as a positive control. The bars in-
dicate the mitochondrial membrane potential in drug-treated trypanosomes
relative to control untreated parasites. The values represent means ± standard
deviations of triplicate determinations from 2 (complex 2) and 3 (complex 9)
independent biological replicates. Statistical analysis was done by Kruskal-
Wallis test, followed by Dunn's multiple comparison test to compare pair-by-
pair. * indicates statistically signiﬁcant diﬀerences (P < 0.05) in TMRE signals
in drug-treated parasites compared to the non-treated control.
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dinuclear thiolate-bridged arene ruthenium complexes against T. b.
brucei bloodstream forms. Of 14 compounds that were initially tested at
250 nM, seven exhibited severe impairment of parasite viability. Six
compounds (1, 2, 5–8) had IC50 values below 10 nM, and two (4, 9)
exhibited IC50 values of around 30 nM.
In line with previous studies showing that complexes 10–14 were
only moderately cytotoxic in vitro against several cancer cell lines (IC50
values between 0.2 and 2.5 μM) (Ibao et al., 2012; Stibal et al., 2014)
and not toxic against T. gondii and N. caninum, they were also not af-
fecting the viability of T. b. brucei bloodstream forms. This may reﬂect
their propensity to easily get hydrolysed compared to their trithiolato
counterparts (Basto et al., 2017, 2019).
Generally, the in vitro activity of anticancer and antiparasitic drugs
can be related in part to their lipophilic character. In general, increasing
hydrophobicity facilitates uptake of a compound by cells or parasites,
thereby enhancing its anti-proliferative activity. We and others have
previously demonstrated correlation between lipophilicity and cyto-
toxic activity for dinuclear arene ruthenium complexes, e.g. in studies
involving the apicomplexan parasites T. gondii and N. caninum (Basto
et al., 2017, 2019). Complexes with log P values in the range between
3.0 and 4.0 showed highest cytotoxicity, whereas complexes with log P
values lower than 3.0 or higher than 4.5 were less active, presumably
due to poor cellular uptake. Generally, less lipophilic compounds have
more diﬃculties to cross membranes or are more rapidly excreted by
exocytosis. Interestingly, as shown in Table 1, the activity of this library
of arene ruthenium complexes against T. b. brucei does not mirror our
ﬁndings obtained earlier in several cancer cells (Giannini et al., 2012,
2013) and in the apicomplexan parasites Toxoplasma gondii and N. ca-
ninum. There is indeed only a poor correlation between lipophilicity
and IC50 values: for instance, complex 1 has a log P value of 3.48 and an
IC50 value of 3 nM, while complex 4 has a similar log P value of 3.44 but
is non-toxic. Similarly, complexes 1, 2, and 5–8 exhibit similar IC50
values between 3 and 9 nM, while their log P values range from 2.20 (8,
hydrophilic) to 4.74 (6, very lipophilic).
The character of the substituents in the thiolato-ligands seems to
play an important role in the diﬀerences in anti-trypanosomal activity,
Fig. 6. Ultrastructure of control (A) and vehicle
(B–F)-treated T. b. brucei visualized by TEM. A is a
low magniﬁcation view of one longitudinal and two
cross-sections; n=nucleus; black arrows point to-
wards portions of the mitochondrion seen in a single
section. B is a higher magniﬁcation view of the boxed
area of the parasite seen in C; fp indicates the ﬂa-
gellar packet, k= kinetoplast, go=Golgi stacks. E
and F are higher magniﬁcation views of the boxed
areas shown in D. Yellow arrows point towards the
mitochondrion, the white arrow in E shows sub-
pellicular microtubules. Bars in A=0.4 μm;
B=0.17 μm; C=1.2 μm; D=1.2 μm; E and
F=0.17 μm. (For interpretation of the references to
colour in this ﬁgure legend, the reader is referred to
the Web version of this article.)
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whereas the position of the substituents in the thiolato-ligands seems to
have little inﬂuence. Whatever the substituent position is, complexes
with heteroatoms exhibit increasing IC50 values that parallel the lipo-
philicity of the corresponding thiol, going from 3 (R=3-C6H4–NH2) to
6 (R=3,5-C6H3-(CF3)2). In contrast, complexes with aliphatic sub-
stituents such as complex 2 (R= 2-C6H4–CH(CH3)2), 4 (R= 3,5-C6H3-
(CH3)2) and 7 (R= 2-C6H4–CH3) exhibit IC50 values that do not cor-
relate with lipophilicity.
Complexes 2 and 9 were further characterized, since the eﬃcacy
and the ultrastructural eﬀects of these compounds have been also as-
sessed previously against T. gondii and N. caninum (Basto et al., 2017,
2019). We here provide evidence that, within 2–4 h of exposure, these
compounds induced severe ultrastructural changes such as mitochon-
drial swelling and dissolution of the cristae, the mitochondrial matrix
and mitochondrial membrane, while other organelles were seemingly
unaﬀected. However, the absence of ultrastructural evidence does not
exclude eﬀects on other aspects of physiology and metabolism, thus it is
possible that these compounds also target other organelles.
In addition, exposure to complex 2 or 9 also reduced the mi-
tochondrial membrane potential in a time- and concentration-depen-
dent manner. Oxidative phosphorylation resulting in generation of ATP
is the major function of mitochondria in eukaryotic cells. However, T. b.
brucei bloodstream forms largely lack this activity (Priest and Hajduk,
1994), but mitochondria are involved in other crucial processes. These
include cell division and cell cycle regulation, t-RNA- and protein-im-
port and mitochondrial protein translation, alternative oxidase, acetate
production for cytosolic and mitochondrial fatty acid biosynthesis, the
glycine cleavage complex/thymidine biosynthesis, production of er-
gosterol-related sterols by a biosynthetic pathway similar to that op-
erating in pathogenic fungi, maintenance of a proper mitochondrial
membrane potential, amino acid metabolism and calcium homeostasis.
Mitochondria are also involved in the steps leading to programmed cell
Fig. 7. TEM carried out after exposure of T. b. brucei to 20 nM complex 2 during 2 h (A, B) or 4 h (E, F). The boxed areas in A and C are magniﬁed in B and D,
respectively. The mitochondrial membrane is indicated by yellow arrows, and the * indicates the less electron dense mitochondrial matrix. E and F show regions
around the ﬂagellar pocket (fp), with the kinetoplast (k), and a rather amorphous and electron-lucent matrix (*). Bars in A = 1.2 μm; B = 0.12 μm; C = 1.2 μm;
D = 0.12 μm; E = 0.22 μm; F = 0.28 μm. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the Web version of this article.)
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death (Fidalgo and Gille, 2011; Zimmer, 2019). In general, the most of
the active complexes in our study are positively charged, whereas none
of the neutral complexes were active. This implies that the positive
charge could be an important factor in mitochondrial uptake of the
complexes as the mitochondrial matrix is negatively charged.
A large panel of compounds has been shown previously to directly
interfere with the mitochondrial ultrastructure in trypanosomatids, si-
milar to the ruthenium compounds investigated here. Hentzer and
Kobayasi (1977) demonstrated the eﬀects of pentamidine on the mi-
tochondria of Leishmania tropica, including mitochondrial swelling,
disappearance of cristae, and changes in the kinetoplast. Similar al-
terations were reported in T. brucei after treatment with pentamidine,
puromycin, acriﬂavine, antrycide, suramin and mapharside
(Williamson et al., 1975). Membrane and cristae fragmentation and
disruption of the kinetoplast core were also reported after treatment of
L. amazonensis with pentamidine. However, changes in the kinetoplast
also occur by abrupt disruption of the mitochondrial membrane po-
tential and perturbation of Ca2+ homeostasis (Vercesi and Docampo,
1992), the former of which we demonstrate here after treatment with
ruthenium complexes 2 and 9.
Inhibitors of ergosterol and phospholipid biosynthesis were also
shown to induce similar eﬀects as seen with complexes 2 and 9. Sterol
methenyl transferase inhibitors dramatically aﬀected the ultrastructure
and physiology of the mitochondrion leading to potent growth inhibi-
tion of promastigotes of L. amazonensis (Rodrigues et al., 2007). The
eﬀects of ergosterol biosynthesis inhibitors have been explained by the
large amounts of endogenous and exogenous sterols present in the
mitochondrial membranes of e.g. T. cruzi (Rodrigues et al., 2001). Er-
gosterol biosynthesis inhibitors induce important alterations in the
phospholipid content of the mitochondrial membranes, with an in-
crease in phosphatidylethanolamine (PE) and a decrease in phosphati-
dylcholine (PC), probably due to inhibition of PE N-methyltransferase
(Palmie-Peixoto et al., 2006). In the case of the phospholipid bio-
synthesis inhibitor miltefosine, studies in Leishmania sp. also demon-
strated lesions in the mitochondrion, with subsequent DNA fragmen-
tation, both characteristics of apoptosis-like cell death (Verma and Dey,
2004). Whether complex 2 and/or 9 interfere in lipid biosynthesis re-
mains to be investigated. It would be surprising that the compounds 2
and 9 target these pathways, as their chemical structures are clearly
diﬀerent from the inhibitors of ergosterol and phospholipid biosynth-
esis.
In the intracellular apicomplexan parasite T. gondii, inhibitors of
Fig. 8. TEM carried out after exposure of T. b. brucei to 200 nM complex 9 during 2 h (A, B) or 4 h (C, D). The section through the trypanosome in A is shown at higher
magniﬁcation in B. Yellow arrows point towards the membranes of the mitochondrion, with a matrix (*) that has lost much of its electron dense content. D shows a
ﬂagellar pocket (fp) and the associated kinetoplast (k) surrounded by a swollen mitochondrion; go = Golgi. Bars in A = 0.7 μm; B = 0.15 μm; C = 0.35 μm;
D = 0.15 μm. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the Web version of this article.)
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ergosterol biosynthesis induced the most severe ultrastructural changes
also in the mitochondrion, displaying intense swelling with a loss of
matrix content (Martins-Duarte et al., 2006). Interestingly, this was also
observed for complex 2 and 9 in T. gondii (Basto et al., 2017) and N.
caninum (Basto et al., 2019). Aﬃnity chromatography of Toxoplasma
soluble extracts on epoxy-sepharose-bound complex 9 identiﬁed T.
gondii translation elongation factor 1-alpha (Tg-EF1-alpha) and two
ribosomal proteins, RPS18 and RPL27, as potential binding proteins
(Basto et al., 2017). In eukaryotic cells, EF1-alpha is an essential
component of protein synthesis, promoting the GTP-dependent transfer
of aminoacylated tRNA to the ribosome A site. Other activities of EF1-
alpha are associated with vital cellular functions related to cell growth,
motility, protein metabolism, signal transduction, DNA replication/re-
pair protein networks, and apoptosis (Toueille et al., 2007; Lamberti
et al., 2007). In T. gondii and T. brucei, EF1-alpha mediates the speci-
ﬁcity of mitochondrial tRNA import (Bouzaidi-Tiali et al., 2007; Esseiva
et al., 2004), and disruption of this process could lead to the observed
mitochondrial alterations. Involvement of EF1-alpha in the mechanism
of action of complexes 2 and 9 should be investigated in further studies.
In conclusion, we demonstrate remarkable changes in the mi-
tochondrion of bloodstream forms of T. b. brucei during short-term
exposure to several ruthenium complexes. Corresponding IC50 values in
trypanosomes are in the lower nanomolar range, and these complexes
exhibit highly favorable selective toxicity indeces as they are not toxic
for human ﬁbroblasts. However, other mammalian cell types need to be
studied ensure proper selective toxicity for protozoan parasites. Future
investigations will focus on extensive structure-activity relationships by
modifying the arene ligands and anchoring bioactive molecules, a
strategy already explored by some of us for this family of complexes
against cancer cells [24]. Furthermore, the functionalization of these
arene ruthenium complexes with ﬂuorescent molecules such as BODIPY
or Coumarin derivatives will enable us to get more insights into their
mechanism of action, most notably on how they impair the mitochon-
drion. Finally, we will examine whether they exert true parasiticidal
activity.
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